BackAgenus Overview
Agenus Inc

Agenus Target Price

See Agenus's analyst price targets ($25) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$8.24

Average Target Price

$25.00203.4% upside

1 analysts in the last 4 months

High: $25 | Low: $25

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-11H.C. Wainwright$25203.4% upsideOpen
2024-11-29H.C. WainwrightEmily Bodnar$715% downsideOpen
2024-07-19JefferiesBiren Amin$715% downsideOpen
2024-07-19Robert W. BairdColleen Kusy$82.9% downsideOpen
2024-07-18H.C. WainwrightEmily Bodnar$99.2% upsideOpen
2024-07-01H.C. WainwrightEmily Bodnar$20142.7% upsideOpen

Agenus (AGEN) FAQ

Agenus posts a target price of $25. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $25 for AGEN means covering analysts, on average, see the stock 203.4% upside of $8.24 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for AGEN's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Agenus's other metric pages and overview cover the third.

Judging Agenus against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $25 here, then scan peer and history charts to see if the gap is persistent.